Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis
Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis
Recruiting · NCT07497399 · Registry updated 2026-07-17Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis | CNS demyelinating autoimmune disease, autoimmune disease, autoimmune disorder of the nervous system, demyelinating disease, immune system disorder, multiple sclerosis, nervous system disorder | Recruiting | Phase 2 | 2026-07-17 | NCT07497399 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Johns Hopkins University | 579 |
| National Multiple Sclerosis Society | 13 |
| Race to Erase MS | 1 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Johns Hopkins University | Baltimore | United States | 150 |
| Mount Sinai School of Medicine | New York | United States | 15 |